Vaughan DE - Search Results

1

Cathepsin D-like aspartyl protease activity mediates the degradation of tissue-type plasminogen activator/plasminogen activator inhibitor-1 complexes in human monocytes.

Simon DI, Xu H, Vaughan DE. Simon DI, et al. Among authors: vaughan de. Biochim Biophys Acta. 1995 Aug 31;1268(2):143-51. doi: 10.1016/0167-4889(95)00063-x. Biochim Biophys Acta. 1995. PMID: 7662701 Free article.

2

Dynamic structural and functional relationships in recombinant plasminogen activator inhibitor-1 (rPAI-1).

Vaughan DE, Declerck PJ, Reilly TM, Park K, Collen D, Fasman GD. Vaughan DE, et al. Biochim Biophys Acta. 1993 Oct 6;1202(2):221-9. doi: 10.1016/0167-4838(93)90008-f. Biochim Biophys Acta. 1993. PMID: 8399383

3

Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function.

Ridker PM, Gaboury CL, Conlin PR, Seely EW, Williams GH, Vaughan DE. Ridker PM, et al. Among authors: vaughan de. Circulation. 1993 Jun;87(6):1969-73. doi: 10.1161/01.cir.87.6.1969. Circulation. 1993. PMID: 8504511

4

Tissue plasminogen activator and acute pulmonary embolism.

Goldhaber SZ, Kessler CM, Heit J, Markis JE, Sharma GV, Dawley DL, Meyerovitz MF, Vaughan DE, Parker JA, Come PC, et al. Goldhaber SZ, et al. Among authors: vaughan de. J Cell Biochem. 1988 Dec;38(4):303-12. doi: 10.1002/jcb.240380409. J Cell Biochem. 1988. PMID: 3149283

5

Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor.

Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Shen C, Newcomer LM, Goldhaber SZ, Hennekens CH. Ridker PM, et al. Among authors: vaughan de. Circulation. 1992 May;85(5):1822-7. doi: 10.1161/01.cir.85.5.1822. Circulation. 1992. PMID: 1572039

6

Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator.

Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ, Hennekens CH. Ridker PM, et al. Among authors: vaughan de. JAMA. 1994 Sep 28;272(12):929-33. doi: 10.1001/jama.1994.03520120039028. JAMA. 1994. PMID: 7794308

7

Prospective study of endogenous tissue plasminogen activator and risk of stroke.

Ridker PM, Hennekens CH, Stampfer MJ, Manson JE, Vaughan DE. Ridker PM, et al. Among authors: vaughan de. Lancet. 1994 Apr 16;343(8903):940-3. doi: 10.1016/s0140-6736(94)90064-7. Lancet. 1994. PMID: 7909008

8

PGE1 accelerates thrombolysis by tissue plasminogen activator.

Vaughan DE, Plavin SR, Schafer AI, Loscalzo J. Vaughan DE, et al. Blood. 1989 Apr;73(5):1213-7. Blood. 1989. PMID: 2495035 Free article.

9

A cross-sectional study of endogenous tissue plasminogen activator, total cholesterol, HDL cholesterol, and apolipoproteins A-I, A-II, and B-100.

Ridker PM, Vaughan DE, Stampfer MJ, Sacks FM, Hennekens CH. Ridker PM, et al. Among authors: vaughan de. Arterioscler Thromb. 1993 Nov;13(11):1587-92. doi: 10.1161/01.atv.13.11.1587. Arterioscler Thromb. 1993. PMID: 8218099 Clinical Trial.

10

Synergistic disaggregation of platelets by tissue-type plasminogen activator, prostaglandin E1, and nitroglycerin.

Stamler JS, Vaughan DE, Loscalzo J. Stamler JS, et al. Among authors: vaughan de. Circ Res. 1989 Sep;65(3):796-804. doi: 10.1161/01.res.65.3.796. Circ Res. 1989. PMID: 2504509

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Search Page

Filters